According to a new report North America Biochips Market, published by KBV research, the North America Biochips Market would witness market growth of 10.6% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Lab-on-Chip Market by Country in 2018, growing at a CAGR of 9.8 % during the forecast period. The Canada market is expected to witness a CAGR of 10.6% during (2019 - 2025). Additionally, The Mexico market is expected to witness a CAGR of 12.8% during (2019 - 2025).
The Drug Discovery and Development market dominated the Canada Biochips Market by Application in 2018, growing at a CAGR of 10.6 % during the forecast period. The Disease Diagnostics market is expected to witness a CAGR of 10.5% during (2019 - 2025). The Genomics market is expected to witness a CAGR of 11.9% during (2019 - 2025).
The Biotechnology and Pharmaceutical Sector market dominated the Mexico Biochips Market by End User in 2018, growing at a CAGR of 12.7 % during the forecast period. The Hospitals and Diagnostics Centers market is expected to witness a CAGR of 12.5% during (2019 - 2025). The Academic and Research Institutes market is expected to witness a CAGR of 14.5% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/north-america-biochips-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Fluidigm Corporation, Horiba Ltd., PerkinElmer, Inc., OriGene Technologies, Inc., Dynamic Biosensors GmbH, Illumina, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Randox Laboratories Limited, Thermo Fisher Scientific, Inc.
ByProduct
By Application
By End User
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
